Top Markets
Coin of the day
Hansa Biopharma AB Hansa Biopharma AB

Hansa Biopharma AB

HNSBF
Clasificación en acciones #15162
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Precio por acción
$3.70
Última sincronización: 2026-08-28
Capitalización bursátil
$369.01M
Cambio (1 día)
0.00%
Cambio (1 año)
35.04%
País
SE
Comercio Hansa Biopharma AB (HNSBF)

Categoría

Historial del precio de la acción de Hansa Biopharma AB (HNSBF)
Precio más alto de cierre: $3.70 el 2026-08-01

Precio más bajo de cierre: $4.71 el 2015-03-01
Historial del precio de la acción de Hansa Biopharma AB desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 7.87%
2025 -0.21%
2024 29.03%
2023 -54.16%
2022 -51.64%
2021 -65.44%
2020 200.34%
2019 -69.02%
2018 10.98%
2017 118.54%
2016 302.77%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$61.61 71.22%
US
$51.02 69.30%
SE
$194.29 41.91%
FR
$62.45 0.05%
IT
$113.45 62.73%
US